Investigators Deepen Criminal Probe Into Chinese Vaccine Producer; Regulators Revoke Production License For Rabies Inoculation
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Executives at leading Chinese drug maker Simcere Pharmaceutical disclosed that regulators have revoked the production license for a rabies vaccine made by recently acquired Jiangsu Yanshen Biological Technology